Methods in Pharmacoepidemiology / Analytical Methods

(A-177) An Alternative to Non-Responder Imputation for Study Participants with Missing Outcomes in Single-Arm Drug Effectiveness Studies: A Case Study in the CorEvitas Psoriasis Registry

(A-195) Estimating artificial censoring weights for clone censor weighting studies: techniques and lessons learned

(A-185) Evaluating Sequence Symmetry Analysis Across Six European Healthcare Databases

(A-174) Evaluating the Robustness of Propensity Score Methods in Survival Analysis Under Sample Size Imbalance: A Monte Carlo Simulation

(A-181) Explainable Artificial Intelligence for Predicting Chemotherapy Toxicity: A Machine Learning Approach Using Pooled Clinical Trial Data

(A-193) Exploring methods for identifying heterogenous treatment effects (HTEs) for second-line type 2 diabetes medications and cardiovascular outcomes

(A-188) Group-Based Trajectory Models to Identify Potential Reasons for Treatment Switch Among Patients with Neovascular Age-Related Macular Degeneration (nAMD)

(A-191) Healthcare Resource Utilization Disruptions During the COVID-19 Era and Methodological Considerations: A Review

(A-194) Intercurrent Events in Estimands: Where RWE meets RCTs

(A-175) Interpretable Machine Learning Models: Describing Treatment Patterns of Healthcare Providers Selecting Rheumatoid Arthritis Therapies to Evaluate Treatment Policies

(A-172) Iterative Causal Survival Forest: A Novel Subgrouping Algorithm for Survival Data Allowing for Censoring

(A-180) Machine Learning Methods for Predicting Adverse Drug Events: A Systematic Review

(A-176) Performance of Machine Learning Predictions of Overall Survival After Multiple Imputations for Features Based on Absolute Non-Missing Degrees

(A-184) Potential for Extreme Bias Due to Outcome Misclassification in Relative Measures of Effect for Rare Time-to-Event Outcomes

(A-173) Recalculating Propensity Score or Not for Subgroup Analysis in Propensity Score Matching and Inverse Probability of Treatment Weighting: A Monte Carlo Simulation Study

(A-189) Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data (RWD): Challenges and Solutions to Avoid Biases that Generate Immortal Time

(A-178) The association between fibrate use and the risk of diabetic peripheral vascular disease in patients with type 2 diabetes mellitus: A nested case-control study

(A-192) Title: Fostering Creativity in AI: Insights from a Datathon Tackling HIV Screening Challenges

(A-179) Transfer Learning Strategies for Addressing Class Imbalance in Drug Adverse Reaction Prediction: Simulation and Empirical Analysis

(A-187) Using a Random Slope Model to Evaluate the Association Between Initial High/Low Opioid Dosage and Kidney Function Change Over One Year Post-Surgical Discharge

(A-190) Using causal trees to explore the heterogeneity of effects

(A-182) Validity of High-Throughput Pharmacoepidemiologic Methods Using Electronic Healthcare Databases for Drug Repurposing Research: Application to Systemic Lupus Erythematosus

(A-183) Why We Should Be Prioritizing the Average Treatment Effect on the Treated Over Other Estimands When Evaluating Medical Product Safety